期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

替莫普利对大鼠血管平滑肌细胞弹性蛋白酶的影响 被引量：1

Effect of Temocapril on the Elastase in Rat Vascular Smooth Muscle Cell
暂未订购
导出
摘要 目的研究替莫普利对大鼠球囊损伤动脉血管平滑肌细胞(VSMC)的弹性蛋白酶水平、表达和活性的影响。方法建立大鼠损伤动脉再狭窄模型,实验组给予盐酸替莫普利,对照组给予药品溶剂。动脉损伤后第2、3、5天测定两组VSMC的弹性蛋白酶ⅢB阳性细胞率;采用原位杂交的方法测定两组弹性蛋白酶ⅡmRNA阳性细胞率;测定两组弹性蛋白酶活性值。动脉损伤后第3天对两组进行原位明胶酶谱分析。动脉损伤后第10天测定两组内膜面积。结果替莫普利组与对照组比较,大鼠损伤动脉VSMC的弹性蛋白酶ⅢB、弹性蛋白酶ⅡmRNA阳性细胞率显著降低,弹性蛋白酶活性显著降低;同时明胶酶水平显著降低,内膜面积显著减小。结论替莫普利可能通过抑制大鼠损伤动脉VSMC的弹性蛋白酶水平、表达和活性及抑制明胶酶水平,抑制损伤动脉内膜肥厚。 Objective To study the effect of temocapril on the level,expression,and activity of elastase in vascular smooth muscle cells （VSMC） in balloon-injured rat artery.Methods The rat model of arterial stenosis induced by artery injury was established.The Wistar rats were treated with temocapril hydrochloride （experimental group） and medicine solution （control group）,respectively.On days 2,3,and 5 after the artery injury,the percentages of cells positive for elastase ⅢB and elastase Ⅱ mRNA and the activity of elastase were determined in both groups.Collagenase in situ zymography was performed on day 3 after the artery injury.The intimal area was measured 10 days after the artery injury.Results Compared with the control group,the percentages of cells positive for elastase ⅢB and elastase Ⅱ mRNA,the activity of elastase,the level of type Ⅳ collagenase,and the intimal area significantly decreased in the experimental group.Conclusion Temocapril may inhibit intimal hypertrophy by inhibiting the level,expression,and activity of elastase and the level of collagenase in VSMCs in the injured artery.
作者 孙娟 舒强 凌光烈
机构地区 中国医科大学附属第一医院局解教研室
出处 《中国医科大学学报》 CAS CSCD 北大核心 2011年第1期42-44,共3页 Journal of China Medical University
关键词 再狭窄 血管紧张素转换酶抑制剂 血管平滑肌细胞 弹性蛋白酶 restenosis angiotensin converting enzyme inhibitor vascular smooth muscle cell elastase
分类号 R453.9 [医药卫生—治疗学]
  • 相关文献

参考文献11

  • 1Zargham R. Preventing restenosis after angioplasty: a multistage ap- proach[J]. Clin Sci (Lond), 2008, 114(4): 257-264.
  • 2Schainfeld RM. Potential emerging therapeutic strategies to prevent restenosis in the peripheralvasculature [J].Catheter Cardiovasc In- terv, 2002, 56(3): 421-431.
  • 3Wu JR, Liou SF, Lin SW, et al. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reduc- ing intracellular reactive oxygen species and inactivating Ras-ERK1/ 2 signaling[J]. Pharmacol Res, 2009, 59( 1 ) : 48-56.
  • 4Wang L, Zheng J, Bai X, et al. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon- injured rat arteries[J]. Circ Res, 2009, 104(5 ) : 688-698.
  • 5Mnjoyan ZH, Doan D, Brandon JL, et al. The critical role of the in- trinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia [J]. Am J Physiol Heart Circ Physiol, 2008, 294(5) : H2276- H2284.
  • 6Kundra V, Anand-Apte B, Feig LA, et al. The chamotacfic re- sponse to PDGF-BB: evidence of a role for ras [J]. J Cell Biol, 1995, 130(4): 725-731.
  • 7Holm AM, Andersen CB, Hauns S, et al. ACE-inhibition promotes apoptosis after balloon injury of rat carotid arteries [J]. Cardiovasc Res, 2000, 45(3): 777-782.
  • 8Fingerle J, Muller RMK, Kuhn H, et al. Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries[J]. Arterioscler Thromb Vasc Biol, 1995, 15(12) : 1945-1950.
  • 9Tsutsui M, Shimokawa H, Tanaka S, et al. Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty [J]. Jpn Circ J, 1996, 60( 1 ) : 27-34.
  • 10Bouallegue A, Vardatsikos G, Srivastava AK. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1-and angiotensin Ⅱ -induced PKB phosphorylation, and hypertrophic and prolifera- tive responses in vascular smooth muscle cells [J]. Can J Physiol Pharmacol, 2009, 87(12) : 1009-1018.

同被引文献13

  • 1Garin-Chesa E Old L J, Rettig W J. Cell surface glycoprotein of reactive stromal fribroblasts as a potential ant ibody target in human epithelial cancers [J] .Proc Natl Acad Sci USA, 1990, 87(18): 7235-9.
  • 2Richard AF, Clark MD. Regulation of fibroplasia in cutaneous wound repair[J]. Am J Med Sci, 1993, 306(1): 42-8.
  • 3Cheng JD, Valianou M, Canutescu AA, et al. Abrogation of fibrolast activation protein enzymatic activity attenuates tumor growth [ J]. Mol Cancer Ther, 2005, 4(3): 351-60.
  • 4Acharya PS, Zukas A, Chandan V, et al. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis[J]. Hum Pathol, 2006, 37(3): 352-60.
  • 5Monsky WL, Lin CY, Aoyama A, et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells[J]. Cancer Res, 1994, 54(21 ): 5702-10.
  • 6陈蕊,邢昌赢,徐道亮,等.维持性皿液透析患者成纤维细胞生长因子23与心血管病变的临床研究[J].实用临床医药杂忠,2010,14(15):9-12.
  • 7赵诗萌,吴红敏,张良,等.E2F1基因在CLD新小鼠9市成纤维细胞中的动态表达及意义[J].中闭医科大学学报,2011,40(2):109-12.
  • 8Huang Y, Wang S, Kelly T. Seprase promotes rapid tt, mor growth and increased mierovessel density in a mouse model of human breast cancer[J]. Cancer Res, 2004, 64(8): 2712-6.
  • 9Aimes RT, Zijlstra A, Hooper JD, et al. Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis[J]. Thromb Haemost, 2003, 89(3): 561-72.
  • 10Santos AM, Jung J, Aziz N, et al. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice[J ]. J Clin Invest, 2009, 119(12): 3613-25.

引证文献1

二级引证文献2

中国医科大学学报
2011年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部